Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Procter & Gamble Co (PG) vs Verisign, Inc. (VRSN) Price & Performance

Procter & Gamble CoTrade
Verisign, Inc.Trade

Price performance (Past 24H)

Key statistics

Procter & Gamble Co vs Verisign, Inc. — how do they compare? Procter & Gamble Co trades at $149.52 (market cap $344.87B), while Verisign, Inc. trades at $262.86 (market cap $24.22B). The key difference: Procter & Gamble Co is far larger — about 14.2× Verisign, Inc.'s market cap, and Procter & Gamble Co pays the higher dividend (2.94%). Which is the better fit depends on your goals.

PGVRSN
Market Cap
$344.87B$24.22B
Volume
6,423,436
Sector
Consumer StaplesTechnology
52-Week High
$167.18$310.00
52-Week Low
$138.10$211.49
Enterprise Value
$370.34B$25.46B
Dividend Yield
2.94%1.22%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Procter & Gamble Co

Procter & Gamble (PG) trades at $149.15, showing minimal daily movement. The stock exhibits neutral technical signals with support near $147 and resistance at $150. Fundamentally, PG maintains stable revenue near $84.3 billion and strong net income margins above 19%, supported by consistent earnings beats. Recent news highlights its dividend reliability amid market volatility, with a 69-year track record of increases. Analyst consensus is bullish with a $160.50 price target, though valuation multiples trade at premiums to peers.

PG offers steady growth with dividend safety but faces near-term headwinds from premium valuations and modest revenue expansion. Upside depends on execution of supply chain efficiencies and sustained consumer demand. Risks include competitive pressures and economic sensitivity. Institutional ownership trends show mixed positioning, reflecting cautious optimism.

Verisign, Inc.

VeriSign (VRSN) trades at $266.15, down 4.15% over the past day, with a mixed technical outlook showing bullish moving averages but overbought oscillators. The company maintains strong fundamentals with 2025 revenue of $1.66 billion, net income of $825.7 million, and a robust net income margin of 49.96%. Recent Q1 2026 earnings beat expectations with EPS of $2.34, while Q2 2026 results are anticipated. Analyst sentiment is predominantly positive with a 57% buy rating and a consensus price target of $325.25, suggesting significant upside potential.

The outlook for VRSN is cautiously optimistic, driven by its monopoly position in .com and .net domain registrations, consistent cash flow generation, and potential tailwinds from AI-driven domain growth. Key risks include contract renewal uncertainties, competitive pressures, and high valuation multiples. Investors should weigh the stock's premium valuation against its stable revenue streams and growth catalysts from digital expansion.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Procter & Gamble Co

The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.

Read more on PG

About Verisign, Inc.

Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.

Read more on VRSN